Why Vir Biotechnology Stock Is Higher Today
1 minuto de lectura
What happenedShares of Vir Biotechnology (NASDAQ: VIR) were 12.6% higher as of 12:47 p.m. EST on Wednesday. The big gain came after Vir and GlaxoSmithKline (NYSE: GSK) announced that they’re expanding their collaboration to include the development of therapies targeting influenzaRead MoreMarketsMarkets Feed
Descubre más desde Espacioteca
Suscríbete y recibe las últimas entradas en tu correo electrónico.
